Abstract Details
|
Tooba Fayyaz, DO, FÂé¶¹´«Ã½Ó³»
PRESENTER |
No disclosure on file |
| Jorina Elbers, MD | No disclosure on file |
| Jillian Edwards, DO | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| David J. Libon, PhD (Rowan Univerity) | No disclosure on file |
| Anahita F. Deboo, MD (Temple University School of Medicine - Neurology) | Dr. Deboo has nothing to disclose. |
| Terry D. Heiman-Patterson, MD (Temple University Lewis Katz School of Medicine) | Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation. |